Company Filing History:
Years Active: 1987
Title: Gonter Weinheimer: Innovator in Cardiovascular Treatments
Introduction
Gonter Weinheimer is a notable inventor based in Denzlingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating vascular diseases. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Weinheimer holds a patent for 4-alkoxy-pyrido[2,3-d]pyrimidine derivatives. This patent describes the compounds and processes for their preparation. These derivatives are recognized for their vasospasmolytic effects, making them valuable in treating cerebral, cardiac, and peripheral vascular diseases. Conditions such as myocardial ischemia, cerebral infarction, and pulmonary thromboses can benefit from these compounds, which also play a role in managing arteriosclerosis and other stenotic disorders. The potential of these agents in combating cardiovascular mortality is significant.
Career Highlights
Gonter Weinheimer is associated with Godecke Aktiengesellschaft, where he continues to innovate in the pharmaceutical sector. His expertise and dedication to research have positioned him as a key figure in the development of cardiovascular treatments.
Collaborations
Weinheimer has collaborated with notable colleagues, including Jorgen Kleinschroth and Gerhard Satzinger. Their combined efforts contribute to advancing research and development in their field.
Conclusion
Gonter Weinheimer's work exemplifies the impact of innovation in medicine, particularly in addressing cardiovascular health challenges. His contributions through patents and collaborations highlight the importance of research in improving patient outcomes.